• Police release video of possible Brown University shooter
  • Dec. 14, 2025, 12:42 AM ESTBy Phil Helsel…
  • Video of possible Brown University shooter released
  • Brown University victims believed to be students, school…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Dec. 9, 2025, 5:27 PM ESTBy Rebecca KeeganFor a company at the center of a chaotic battle over the future of Hollywood, Warner Bros. Discovery had a pretty good Monday.The media conglomerate’s film “One Battle After Another” and TV show “The White Lotus” collected the most Golden Globe nominations in their categories. Another of its movies, “Sinners,” also fared well, earning seven nominations.But the studio did not have much time to celebrate. Just as actors Marlon Wayans and Skye P. Marshall were calling the names of Golden Globe nominees at a news conference at the Beverly Hilton, Paramount launched a hostile takeover bid for WBD valued at more than $108 billion.WBD’s board and shareholders are weighing competing offers for the studio from Netflix and Paramount. Meanwhile, voters in Hollywood are beginning their deliberations as award season ramps up. Many of the seven Hollywood insiders NBC News spoke with — including producers, marketers and former studio executives — said the looming media merger will shape votes for upcoming awards shows, including the Directors Guild Awards, the Screen Actors Guild Awards and the coveted Academy Awards.“This deal is an emotional piece of news for a lot of people,” said “Silence of the Lambs” producer Edward Saxon, a voting member of the Academy of Motion Picture Arts and Sciences and chair of the producing program at the University of Southern California’s film school. “There’s worry about consolidation and about the future of theatrical. The feeling is I don’t get a vote on so much of what’s happening in the industry right now. If I do have a vote on something, I’m going to vote against consolidation.”Warner Bros. Discovery CEO David Zaslav; Paramount Skydance CEO David Ellison; Netflix co-CEO Ted Sarandos. JC Olivera / Kyle Grillot / Getty ImagesMonths of speculation about the future of WBD came to a head last week. On Friday, WBD’s board agreed to sell the company’s film, TV and streaming assets to Netflix for $82.7 billion, sparking a backlash from Hollywood guilds, movie theater owners and politicians on both sides of the aisle over a deal they say would harm workers and consumers.The deal came as something of a surprise. Paramount had been linked to WBD since September, and Netflix co-CEO Greg Peters had publicly downplayed Netflix’s interest.Some academy members say the possibility of Netflix’s owning Warner Bros., one of the last five traditional movie studios in Hollywood, is cementing their aversion to its business model.“There isn’t any love lost for Netflix in the industry right now,” said a veteran academy member who requested anonymity because of the sensitivity of the issue. “The industry feels like they’re a TV company masquerading as a film company.” In a conference call with investors and the media Friday, co-CEO Ted Sarandos said that Netflix has no “opposition to movies in theaters” and that it would uphold Warner Bros.’ existing theatrical agreements. But he also said that “over time the [theatrical] windows will evolve.”On Monday, Netflix was hit with a consumer lawsuit seeking to block the WBD acquisition on the grounds that it threatens to reduce competition. “We believe this suit is meritless and is merely an attempt by the plaintiffs bar to leverage all the attention on the deal,” a Netflix spokesperson said. Netflix has released 10 best picture nominees in its history, beginning with Alfonso Cuarón’s “Roma” in 2019, but it has never won the film industry’s biggest prize, in part because of an industry perception that its business model has contributed to the decline of the theatrical movie business. Golden Globe nominations: Find out which movies and shows topped the list04:21This year, the company has contenders in Guillermo del Toro’s “Frankenstein,” the George Clooney vehicle “Jay Kelly” and the animated musical sensation “KPop Demon Hunters.” Some in Hollywood have defended Netflix from criticism, saying it has opened the door to more creative people. “There are some people that only get their chance because of streamers,” actor Joel Edgerton, whose quiet drama “Train Dreams” Netflix bought at Sundance last year, told Variety at the Gotham Awards in New York this month.Other awards voters say they may give a boost to Warner Bros.’ contending titles, Paul Thomas Anderson’s “One Battle After Another” and Ryan Coogler’s “Sinners.” “There’s a feeling of this year being the last hurrah for Warner,” said another academy member, who requested anonymity so as not to offend Netflix. “There’s sympathy for the people who work there and what they’re going through. And the heads of the film studio [Mike De Luca and Pam Abdy] are well-loved.”In an interview with The Hollywood Reporter about his film’s seven Golden Globe nominations Monday, Coogler answered a question about the pending WBD deal by saying, “Theatrical releases mean everything to me,” a diplomatic way of signaling worry about a Netflix deal.Paramount and Netflix will face regulatory hurdles if their offer prevails. Paramount has consistently touted its close ties to the White House as an advantage over other bidders, and, according to Securities and Exchange Commission filings, some of its financial backing for the deal comes from Affinity Partners, an investment firm founded by Jared Kushner, President Donald Trump’s son-in-law. Paramount has less of a stake in this year’s awards race, apart from “Mission: Impossible—The Final Reckoning,” which is likely to contend in technical categories like sound and visual effects at the Oscars. But the studio owns CBS and Paramount+, which next month will broadcast and stream the Golden Globes, an event that functions as a marketing vehicle for the nominated films and a low-stakes party for Hollywood. At last year’s Globes, which aired two weeks before Trump was inaugurated for his second term and several months before David Ellison’s Skydance bought the network, host Nikki Glaser poked fun at Hollywood’s liberal but largely ineffectual politics. “I’m not here to roast you,” Glaser said. “And how could I? You’re all so famous, so talented, so powerful. I mean, you could really do anything — except tell the country who to vote for. But it’s OK. You’ll get them next time!”A spokesperson for Glaser did not respond to a question about whether her set will include political humor this year.Rebecca KeeganRebecca Keegan is the senior Hollywood reporter for NBC News Digital, where she covers the entertainment industry.

admin - Latest News - December 10, 2025
admin
7 views 10 secs 0 Comments




For a company at the center of a chaotic battle over the future of Hollywood, Warner Bros.



Source link

TAGS:
PREVIOUS
Dec. 9, 2025, 11:27 PM ESTBy Evan BushAfter a string of poisonings from “death cap” mushrooms — one of them fatal — California health officials are urging residents not to eat any foraged mushrooms unless they are trained experts. Doctors in the San Francisco Bay Area have blamed the wild mushroom, also called Amanita phalloides, for 23 poisoning cases reported to the California Poison Control System since Nov. 18, according to Dr. Craig Smollin, medical director for the system’s San Francisco division.“All of these patients were involved with independently foraging the mushrooms from the wild,” Smollin, who is a professor of emergency medicine at the University of California, San Francisco, said at a news conference Tuesday. “They all developed symptoms within the first 24 hours, including nausea, vomiting, diarrhea and abdominal pain.” Smollin said some of the patients were parts of cohorts that had consumed the same batch of foraged mushrooms. The largest group was about seven people, he said. All of the patients were hospitalized, at least briefly. One died. Five remain in hospital care. One has received a liver transplant, and another is on a donation list awaiting a transplant, Smollin said. The patients are 1½ to 56 years old. Mushroom collectors said death cap mushrooms are more prevalent in parts of California this season than in years past, which could be driving the increase in poisonings. “Any mushroom has years that it’s prolific and years that it is not. … It’s having a very good season,” said Mike McCurdy, president of the Mycological Society of San Francisco. He added that the death cap was one of the top two species he identified during an organized group hunt for fungi last week, called a foray. In a news release, Dr. Erica Pan, California’s state public health officer, warned that “because the death cap can easily be mistaken for edible safe mushrooms, we advise the public not to forage for wild mushrooms at all during this high-risk season.”Dr. Cyrus Rangan, a pediatrician and medical toxicologist with the California Poison Control System, said the “blanket warning” is needed because most people do not have the expertise to identify which mushrooms are safe to eat.Still, he said, “it’s rare to see a case series like this.”The California Poison Control System said in a news release that some of the affected patients speak Spanish and might be relying on foraging practices honed outside the United States. Death cap mushrooms look similar to other species in the Amanita genus that are commonly eaten in Central American countries, according to Heather Hallen-Adams, the toxicology chair of the North American Mycological Association. Because death caps are not often found in that region, foragers might not realize the potential risk of lookalikes in California, she said. Anne Pringle, a professor of mycology at the University of Wisconsin-Madison, said there is a litany of poisoning cases in which people misidentify something because their experience is not relevant to a new region: “That’s a story that comes up over and over again.”An Amanita phalloides mushroom in Hungary. The species originated in Europe and is invasive in the U.S. Anne PringleOver the past 10 years, mushroom foraging has boomed in the Bay Area and other parts of the country. At the same time, information resources about mushroom toxicity — reliable and otherwise — have proliferated, as well, including on social media, phone apps and artificial intelligence platforms. Experts said those sources should be viewed with skepticism. Longtime mushroom hunters maintain that the practice can be done safely. McCurdy, who has collected and identified mushrooms since the 1970s, said he bristled at the broad discouragement of foraging. “No, that’s ridiculous. … After an incident like this, their first instinct is to say don’t forage,” he said. “Experienced mushroom collectors won’t pay any attention to that.” But McCurdy suggested that people seek expertise from local mycological societies, which are common in California, and think critically about the sources of information their lives may be relying on. Pringle and McCurdy both said they have seen phone apps and social media forums misidentify mushrooms. “I have seen AI-generated guidebooks that are dangerous,” Pringle said.The death cap is an invasive species that originated in Europe and came to California in the 1930s, most likely with imported nursery trees. The mushroom is usually a few inches tall with white gills, a pale yellow or green cap and often a ring around the base of its stalk. The species is found across the West Coast and the Eastern Seaboard, as well as in Florida and Texas, according to Hallen-Adams, who is also an associate professor of food science at the University of Nebraska-Lincoln. In California, it typically grows near oak trees, though occasionally pines, too. The mushroom’s body is typically connected to tree roots and grows in a symbiotic relationship with them. The toxin in death cap mushrooms, called amatoxin, can damage the kidneys, liver and gastrointestinal tract if it is ingested. It disrupts the transcription of genetic code and the production of proteins, which can lead to cell death.Hallen-Adams said the U.S. Poison Centers average about 52 calls involving amatoxin each year, but “a lot of things don’t get called into poison centers — take that with a grain of salt.” Amatoxin poisoning is not the most common type from mushrooms, but it is the most dangerous, she added: “90% of lethal poisonings worldwide are going to be amatoxin.” It takes remarkably little to sicken a person.“One cubic centimeter of a mushroom ingested could be a fatal dose,” Hallen-Adams said. Symptoms of amatoxin poisoning often develop within several hours, then improve before they worsen. There is no standard set of medical interventions that doctors rely on. “It’s a very difficult mushroom to test for,” Rangan said, and “also very difficult to treat.”One drug that doctors have leaned on to treat some of the California patients — called silibinin — is still experimental and difficult to obtain.“All of our silibinin comes from Europe,” Hallen-Adams said. Death cap mushrooms have continued to grow abundantly since their introduction, and Pringle’s research has shown that the species can reproduce bisexually and unisexually — with a mate or by itself, alone — which gives it an evolutionary advantage. “If Eve can make more of herself, she doesn’t need Adam,” Pringle said. “One of the things I’m really interested in is how you might stop the invasion, how you might cure a habitat of its death caps. And I have no solutions to offer you at the moment.” Evan BushEvan Bush is a science reporter for NBC News.
NEXT
Trump touts economic policies as recent polls show disapproval
Related Post
October 7, 2025
Oct. 6, 2025, 5:00 AM EDT / Updated Oct. 6, 2025, 8:02 PM EDTBy Sahil Kapur, Julie Tsirkin and Frank Thorp VWASHINGTON — The U.S. government shutdown entered its sixth day Monday with no end in sight after the Senate yet again rejected competing bills proposed by Republicans and Democrats to reopen the government.The vote on the Democratic bill was 45-50, while the final tally on the GOP measure was 52-42, with neither reaching the 60-vote threshold to break a filibuster and advance for final passage.One hour before the vote, President Donald Trump left senators flummoxed after he claimed that there were negotiations taking place on health care. The central Democratic demand in the standoff is to extend expiring Obamacare funds.”We have a negotiation going on right now with the Democrats that could lead to very good things. And I’m talking about good things with regard to health care,” Trump told reporters.Asked specifically whether he’s speaking to Democratic leaders, Trump replied: “I don’t want to say that. But we are speaking with the Democrats. But some very good things could happen with respect to health care.”But Senate Minority Leader Chuck Schumer, D-N.Y., quickly shot down Trump’s claim that negotiations are happening.“Trump’s claim isn’t true — but if he’s finally ready to work with Democrats, we’ll be at the table,” Schumer said in a statement. “For months, Democrats have been calling on Donald Trump and Congressional Republicans to come to the table and work with us to deliver lower costs and better health care for the American people.”We’d like to hear from you about how you’re experiencing the government shutdown, whether you’re a federal employee who can’t work right now or someone who is feeling the effects of shuttered services in your everyday life. Please contact us at tips@nbcuni.com or reach out to us here.Republicans similarly said they’re unaware of any bipartisan negotiations taking place on health care.”I’m not aware of any,” Sen. Mike Crapo, R-Idaho, the chair of the Finance Committee, which oversees health care, told NBC News. “I think Sen. Thune made it very clear: We’ll talk about it if we get out of the government shutdown.”Sen. Mike Rounds, R-S.D., said that it’s “good” if Trump is open to extending Obamacare money, but no such talks were happening yet.”But that’s still not going to happen until we actually get this government open,” Rounds said.Senate Majority Leader John Thune, R-S.D., has not committed to extending the Obamacare money, saying it’s a discussion he’s open to having — but only if Democrats relent and reopen the government.“Release the hostage. We’ll have that conversation,” Thune said on Fox News. “That is a program, by the way, that is desperately in need of reform. You cannot just extend it, flat extend it. It is too flawed.”Sen. Elizabeth Warren, D-Mass., said the president’s comments show that “Donald Trump is feeling the heat.”“People across this country do not want to see their insurance premiums double or even triple,” she said.Sen. Angus King, I-Maine, said he was “delighted” to hear Trump’s comments, “and I hope that can lead to some fruitful discussion.” And Sen. Jeanne Shaheen, the lead author of the bill to extend Obamacare funding, said she hasn’t spoken to the president.Again, King was one of just three Democratic caucus members who voted for the GOP bill, along with Sens. John Fetterman, D-Pa., and Catherine Cortez Masto, D-Nev.Trump is declining to take a clear position on whether to extend Obamacare subsidies, the main Democratic demand and a central sticking point in the standoff. The subsidies are set to expire at the end of the year, which would result in major health insurance premium increases for people on the Affordable Care Act.“We want to fix it so it works,” Trump said Sunday when NBC News asked him whether he’s open to extending the funding. “It’s not working. Obamacare has been a disaster for the people, so we want to have it fixed so it works.”House members were supposed to return to Washington this week, but Speaker Mike Johnson, R-La., canceled votes for the entire week, saying the chamber had already done its job and passed a funding bill back on Sept. 19.Democratic House Leader Jeffries speaks out on shutdown, health care03:47Some members of both parties, however, say that’s an attempt by Johnson to avoid a vote to require the Justice Department to release the Jeffrey Epstein files. A bipartisan House duo is expected to have the signatures they need to force a vote on the Epstein issue when the House returns to Washington and Rep.-elect Adelita Grijalva, D-Ariz., is sworn in.Rep. Thomas Massie, R-Ky., said on X: “Why are we in recess? Because the day we go back into session, I have 218 votes for the discharge petition to force a vote on releasing the Epstein files. @SpeakerJohnson doesn’t want that to be the news.”Johnson denied that’s the reason.“This has nothing to do with that,” he said Sunday on NBC News’ “Meet the Press.” “It’s another red herring. The reason the government is closed is because Chuck Schumer and 43 of his Democratic colleagues in the Senate have decided now to vote multiple times to keep the government closed.”In the battle of public opinion, the White House and the GOP are taking more of the blame for the shutdown than Democrats. A new CBS News poll shows that trend continuing, with 39% saying they mostly blame Trump and Republicans, while 30% blame Democrats in Congress and 31% blame both equally.Asked Monday on NBC’s “TODAY” show to react to Trump’s comments on ACA funding over the weekend, Jeffries was unimpressed.“He also mentioned that in the White House meeting that we had last Monday,” Jeffries said. “Unfortunately, the White House and Republican leaders have gone radio silent ever since then.”Sahil KapurSahil Kapur is a senior national political reporter for NBC News.Julie TsirkinJulie Tsirkin is a correspondent covering Capitol Hill.Frank Thorp VFrank Thorp V is a producer and off-air reporter covering Congress for NBC News, managing coverage of the Senate.
October 18, 2025
Crowds gather for 'No Kings' protest in Miami
September 22, 2025
U.S. ambassador to Israel says embassy wasn’t informed before Israeli strike on Doha
November 24, 2025
Nov. 24, 2025, 3:54 PM EST / Updated Nov. 24, 2025, 4:12 PM ESTBy Steve KopackStocks rallied on Monday as investors digested fresh comments from top Fed officials and AI companies rebounded from last week.The S&P 500 ended the day higher by 1.6%. The Nasdaq Composite wrapped the trading day up 2.7%, its best day since May. The S&P 500 came within striking distance of achieving the same feat earlier in the session.The rally came after two top Fed officials voiced support for an interest rate cut at the central bank’s next rate-setting meetings, slated for Dec. 9 and 10.Mary Daly, president of the Federal Reserve Bank of San Francisco, told The Wall Street Journal that she supported lowering rates due to the “vulnerable” labor market. While Daly is not a current voting member of the Fed’s Open Market Committee,” she has rarely taken a public position at odds with Fed Chair Jerome Powell,” the Journal noted.Federal Reserve Governor Christoper Waller, who has a permanent vote on interest rates, also voiced concern about the labor market on Fox Business Network. “My concern is mainly [the] labor market in terms of our dual mandate,” Waller said. “So I’m advocating for a rate cut at the next meeting.” While Waller has been advocating for a cut for months, his and Daly’s views come as markets try to work out how the upcoming Fed meeting will go. In recent days, markets viewed a rate cut as unlikely amid a wave of cautious comments from Fed officials. That all changed on Friday, when New York Fed President John Williams signaled his support for a cut and sent the chance of a rate cut soaring to around 60%. Williams also serves as vice chair of the Fed’s rate-setting committee.New company aims to integrate AI with human work03:09As of Monday afternoon, odds of a cut sat above 85%, according to the CME Group’s FedWatch, which tracks bets that traders place in the futures market on where they see interest rates going.Markets are closely tracking Fed officials because lower interest rates tend to lower borrowing costs, boosting corporate profits and therefore stock market returns.Meanwhile, a sharp rebound in megacap tech stocks also pushed indexes higher. Apple and Nvidia rose around 2%, Amazon shares jumped 2.5% and Alphabet shares surged 6.3%. Last week, Alphabet’s Google division announced a new AI model called Gemini 3.Chipmakers for AI devices and services also saw broad enthusiasm. Broadcom traded higher by more than 11% while Micron jumped 8% and AMD popped 5.5%. Steve KopackSteve Kopack is a senior reporter at NBC News covering business and the economy.
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved